Yi Yang
Président chez Shanghai Genext Medical Technology Co., Ltd.
Profil
Yi Yang has held the following positions in his career: Chairman-Supervisory Board at Shanghai Genext Medical Technology Co., Ltd.
since 2021, and Executive Director at Legend Capital Co. Ltd.
since 2011.
Postes actifs de Yi Yang
| Sociétés | Poste | Début |
|---|---|---|
Legend Capital Co. Ltd.
 Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital Co. Ltd (Legend Capital) is a private equity venture capital subsidiary of Legend Holdings Corp. founded in 2001 by Zhu Li Nan. The firm is headquartered in Beijing, China. | Private Equity Investor | 01/01/2011 |
Shanghai Genext Medical Technology Co., Ltd.
 Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Président | 01/01/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Legend Capital Co. Ltd.
Legend Capital Co. Ltd. Investment ManagersFinance Legend Capital Co. Ltd (Legend Capital) is a private equity venture capital subsidiary of Legend Holdings Corp. founded in 2001 by Zhu Li Nan. The firm is headquartered in Beijing, China. | Finance |
Shanghai Genext Medical Technology Co., Ltd.
Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Health Technology |
